Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Feb;47(2):408-416.
doi: 10.1111/aor.14435. Epub 2022 Nov 8.

Additive effectiveness of acrylonitrile-co-methallyl sulfonate surface-treated membranes in the treatment of pneumonia: A propensity score-matched retrospective cohort study

Kentaro Hayashi  1   2 , Yusuke Sasabuchi  2 , Hiroki Matsui  3 , Mikio Nakajima  3   4 , Hiroyuki Ohbe  3 , Kiyohide Fushimi  5 , Kazuyuki Ono  1 , Hideo Yasunaga  3
Affiliations

Additive effectiveness of acrylonitrile-co-methallyl sulfonate surface-treated membranes in the treatment of pneumonia: A propensity score-matched retrospective cohort study

Kentaro Hayashi et al. Artif Organs. 2023 Feb.

Abstract

Background: The acrylonitrile-co-methallyl sulfonate surface-treated (AN69ST) membrane has cytokine adsorption capacity and is used for treating sepsis. This study aimed to compare the effects of continuous renal replacement therapy (CRRT) using the AN69ST membrane with those of CRRT using other membranes for patients with pneumonia-associated sepsis.

Methods: This retrospective, propensity score-matched, cohort study was based on a nationwide Japanese inpatient database. We included data from adults hospitalized with a primary diagnosis of pneumonia, who received CRRT using either the AN69ST membrane or another membrane within 2 days of admission, and who were discharged from the hospitals between September 2014, and March 2017. Propensity score matching was used to compare in-hospital mortality between the two groups.

Results: Eligible patients (N = 2393) were categorized into an AN69ST group (N = 631) and a non-AN69ST group (N = 1762). The overall in-hospital mortality rate was 38.9%. Among the 545 propensity-matched patient pairs, the in-hospital mortality rate was significantly lower in the AN69ST group than in the non-AN69ST group (35.8 vs. 41.8%, p = 0.046).

Conclusions: Among patients with pneumonia-associated sepsis treated with CRRT, CRRT with the AN69ST membrane was associated with a significantly lower in-hospital mortality than CRRT with standard membranes.

Keywords: acrylonitrile-co-methallyl sulfonate membrane; continuous renal replacement therapy; cytokine adsorption therapy; pneumonia; sepsis.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

FIGURE 1
FIGURE 1
CONSORT flow chart. AN69ST, acrylonitrile‐co‐methallyl sulfonate surface‐treated membrane; CRRT, continuous renal replacement therapy.
FIGURE 2
FIGURE 2
Kaplan–Meier survival curves for 90‐day mortality according to the group after propensity score matching. AN69ST, acrylonitrile‐co‐methallyl sulfonate surface‐treated membrane.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003. Apr 17;348(16):1546–54. - PubMed
    1. Severiche‐Bueno D, Parra‐Tanoux D, Reyes LF, Waterer GW. Hot topics and current controversies in community‐acquired pneumonia. Breathe. 2019. Sep;15(3):216–25. - PMC - PubMed
    1. Menéndez R, Martínez R, Reyes S, Mensa J, Filella X, Marcos MA, et al. Biomarkers improve mortality prediction by prognostic scales in community‐acquired pneumonia. Thorax. 2009. Jul;64(7):587–91. - PubMed
    1. Zhou F, Peng Z, Murugan R, Kellum JA. Blood purification and mortality in sepsis: a meta‐analysis of randomized trials. Crit Care Med. 2013. Sep;41(9):2209–20. - PMC - PubMed
    1. Paats MS, Bergen IM, Hanselaar WE, Groeninx van Zoelen EC, Hoogsteden HC, Hendriks RW, et al. Local and systemic cytokine profiles in nonsevere and severe community‐acquired pneumonia. Eur Respir J. 2013. Jun;41(6):1378–85. 10.1183/09031936.00060112 - DOI - PubMed